Hims & Hers Health (HIMS) Operating Expenses (2019 - 2026)
Hims & Hers Health (HIMS) reported Operating Expenses of $475.1 million for Q1 2026, up 27.45% on a YoY basis from $372.8 million in Q1 2025, and up 9.16% sequentially from $435.2 million in Q4 2025.
Hims & Hers Health (HIMS) Operating Expenses (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Operating Expenses data on file, last reported at $475.1 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 27.45% year-over-year to $475.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (up 36.78% YoY), and the FY2025 full-year result was $1.6 billion, up 46.48% from the prior year.
- Operating Expenses advanced to $475.1 million in Q1 2026, from $435.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $475.1 million in Q1 2026 to a low of $91.7 million in Q1 2022.
- A 5-year average of $260.9 million and a median of $219.2 million in 2024 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses increased 3.41% in 2022 and jumped 79.64% in 2023, its largest moves.
- Tracing HIMS's Operating Expenses over 5 years: stood at $143.9 million in 2022, then soared by 42.04% to $204.5 million in 2023, then surged by 71.65% to $350.9 million in 2024, then gained by 24.02% to $435.2 million in 2025, then gained by 9.16% to $475.1 million in 2026.
- Business Quant data shows HIMS's Operating Expenses at $475.1 million in Q1 2026, $435.2 million in Q4 2025, and $430.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 455.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 475.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 475.11 Mn |
| Dec 31, 2025 | 435.25 Mn |
| Sep 30, 2025 | 430.25 Mn |
| Jun 30, 2025 | 389.47 Mn |
| Mar 31, 2025 | 372.79 Mn |
| Dec 31, 2024 | 350.95 Mn |
| Sep 30, 2024 | 295.51 Mn |
| Jun 30, 2024 | 245.58 Mn |
| Mar 31, 2024 | 219.19 Mn |
| Dec 31, 2023 | 204.46 Mn |
| Sep 30, 2023 | 195.86 Mn |
| Jun 30, 2023 | 179.39 Mn |
| Mar 31, 2023 | 164.69 Mn |
| Dec 31, 2022 | 143.94 Mn |
| Sep 30, 2022 | 134.44 Mn |
| Jun 30, 2022 | 107.37 Mn |
| Mar 31, 2022 | 91.68 Mn |
| Dec 31, 2021 | 83.66 Mn |
| Sep 30, 2021 | 82.53 Mn |
| Jun 30, 2021 | 64.68 Mn |